RFL

Latest SEC Filings & News for RFL

2 most recent filings and news items mentioning RFL. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/RFL/news?limit=20"

Pull RFL filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
RegulatoryJun 11, 2026Positive

Rafael Holdings completes Phase 3 NPC trial, plans NDA submission in H2 2026

Rafael Holdings completed enrollment in its pivotal Phase 3 TransportNPC trial for Niemann-Pick disease Type C and expects to submit an NDA in the second half of 2026 following a pre-NDA FDA meeting. The company reported Q3 net loss of $4.2 million with $30.5 million in cash, pos

View filing at SEC.gov →
RegulatoryJun 10, 2026Positive

Rafael Holdings completes Phase 3 TransportNPC trial for Trappsol Cyclo

Rafael Holdings announced completion of its pivotal Phase 3 TransportNPC study evaluating Trappsol Cyclo for Niemann-Pick Disease Type C treatment, with 94 patients across 27 sites. The company expects to submit an NDA to the FDA in the second half of 2026, positioning the compan

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.